Evidence was found for the existence of an episome-specified variant of the enzyme dihydropteroate synthase involved in folic acid formation. Since the plasmid-borne enzyme showed a decreased susceptibility for sulfonamide inhibition and was transferable together with resistance to this drug, it is proposed that diploidy for the target enzyme in some cases could be the mechanism of R-factor-mediated resistance to sulfonamides. Two types of evidence were obtained. One was the rescue from temperature sensitivity of bacterial mutants with a lesion in the chromosomal dihydropteroate synthase by the R factor R1drl9 mediating sulfonamide resistance. The other evidence was found by the determination of dihydropteroate forming activity in extracts from R-and R+ bacteria. Cells harboring Rldr19 were found to contain an enzyme activity which was far less susceptible to sulfonamide inhibition than the corresponding activity from R-cells.
Evidence was found for the existence of an episome-specified variant of the enzyme dihydropteroate synthase involved in folic acid formation. Since the plasmid-borne enzyme showed a decreased susceptibility for sulfonamide inhibition and was transferable together with resistance to this drug, it is proposed that diploidy for the target enzyme in some cases could be the mechanism of R-factor-mediated resistance to sulfonamides. Two types of evidence were obtained. One was the rescue from temperature sensitivity of bacterial mutants with a lesion in the chromosomal dihydropteroate synthase by the R factor R1drl9 mediating sulfonamide resistance. The other evidence was found by the determination of dihydropteroate forming activity in extracts from R-and R+ bacteria. Cells harboring Rldr19 were found to contain an enzyme activity which was far less susceptible to sulfonamide inhibition than the corresponding activity from R-cells.
Resistance to sulfonamides mediated by R factors has been known for a long time. It was in fact one of the first plasmid-borne resistance determinants observed (4) . However, its biochemical mechanism has not been very well understood. Chromosomal resistance to sulfonamides in Escherichia coli, on the other hand, was in some cases clearly shown (7) to be due to an altered dihydropteroate synthase (8) (EC 2.5.1.15) with a decreased susceptibility to sulfonamide inhibition.
Two general types of biochemical mechanisms for R-factor-mediated resistance to antibiotics have been known for several years. Either the added antibiotic is modified by episomal enzymes or the R factor induces permeability changes (9) . Recently, a third type of mechanism for extrachromosomal drug resistance was described from this laboratory, namely, the R-factor-borne gene for the formation of a drug-resistant target enzyme. The reported case was an episomal, drug-resistant dihydrofolate reductase, making the bacterium diploid for this enzyme and highly resistant to trimethoprim (10; Skold and A. Widh, Proc. Soc. Gen. Microbiol., 1:66, 1974). The mechanism of plasmid-borne sulfonamide resistance invites an analogous explanation, and the present investigation presents evidence for this by demonstrating that an R factor mediating sulfonamide resistance makes a strain ofE. coli diploid for the folic acid-synthesizing enzyme dihydropteroate synthase.
Two approaches were taken. One was to obtain conditionally lethal mutants of bacteria with a temperature-sensitive dihydropteroate synthase and then look for suppression of the temperature sensitivity by the introduction into these mutants of R factors carrying sulfonamide resistance. Mutants with temperaturesensitive lesions in the pteroate-synthesizing enzyme were primarily selected for as sulfonamide-resistant bacteria since, as mentioned above, it was shown earlier (7) that most of such mutants could be expected to carry changes in this enzyme.
The other approach was to compare the sulfonamide susceptibility of the dihydropteroateforming activity in extracts from bacteria with and without an R factor mediating sulfonamide resistance. This was done by the microbiological assay of 7,8-dihydropteroic acid formed in an incubation system containing 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine and paminobenzoic acid.
MATERIALS AND METHODS Bacterial strains. The E. coli C strain C-167 uracil-, strr (11) was supplied by G. Bertani. For use as recipient in R factor transfer experiments it was made resistant to nalidixic acid. The derepressed R factor Rldrl9 carrying resistance to sulfonamides, chloramphenicol, ampicillin, streptomycin, and kanamycin (6) was supplied by E. Meynell. It was harbored in E. coli K-12 strain J53 pro-, met-(3), which was used as the donor in transfer experiments. 49 ANwNacRoB. AGENTS CHEMOTHER.
Media. All experiments were carried out in a mineral salts medium containing the following (per liter): 12.0 g of tris(hydroxymethyl)aminomethane, 2.0 g of KCl, 2.0 g of NHC1, 0.5 g of MgCl2-6H20, 0.050 g of Na2SO4, 0.178 g of Na2HPO4-2H20, and 0.5 g of Casamino Acids (Difco, certified); the pH was adjusted to 7.6 with HCl, and after autoclaving 5 g of glucose and FeCl3 to 10-5 M were added. When needed, supplements of uracil (40 ,ug/ml) and required amino acids (50 itg/ml) were added. For pteroate determinations, Streptococcus faecalis (ATCC 8043) was grown in micro inoculum broth (Difco), and as assay medium, folic acid assay medium (Difco) was used.
Chemicals. Amino acids, uracil, thymidine, deoxyadenosine, adenosine 5'-triphosphate, folic acid, and p-aminobenzoic acid were products of Sigma Chemical Co. (Saint Louis, Mo.). Chloramphenicol and nalidixic acid were gifts from Parke, Davis & Co. (Detroit, Mich.), and Sterling-Winthrop Group Ltd. (Surbiton-on-Thames, England), respectively. Sulfathiazole was a product of Astra Lakemedel AB (Sodertalje, Sweden). The pteroic acid precursor 2-amino-4-hydroxy-6-hydroxymethylpteridine was a gift from Brian Pring (Astra Lakemedel AB, Sodertalje, Sweden). It was reduced to its 7,8-dihydroform with dithionite by the method of Blakely (1).
Preparation of enzyme. Extracts for the assay of dihydropteroate synthase were prepared from strain C-167 with and without the R factor and from the sulfathiazole-resistant, thermosensitive mutants C-167ts18 and C-167ts20. Cells were grown with aeration in supplemented minimal medium at 30 C. Sulfathiazole (0.02 mM) was added for C-167-(Rldrl9), C-167ts18, and C-167ts20. After harvesting, washing, and the final suspension in about 0.05 culture volume of minimal medium, the cells were frozen and disintegrated in a pressure cell (X-press, Biotec, Stockholm, Sweden). The disrupted cells were treated with deoxyribonuclease and centrifuged for 1 h at 105,000 x g. To supernatants a saturated solution of ammonium sulfate (pH 7.0) was added to give a final concentration of 90% saturation. The precipitated protein was dissolved in 0.05 M potassium phosphate buffer (pH 7.0) and finally dialyzed overnight against 200 volumes of the same buffer in the cold. Protein content was estimated by the method of Lowry et al. (5) with the use of trypsin (Sigma Chemical Co.) as a standard.
Assay of enzyme. Determination of dihydropteroate synthase activity was performed mainly by the procedure described by Pato and Brown (7) ; the assay mixture contained 0.025 mM p-AB(p-aminobenzoic acid), 0.04 mM H2-pteridine-CH2OH(2amino-4hydroxy-6-hydroxymethyl-7,8-dihydropteridine), 5 mM adenosine 5'-triphosphate, 10 mM MgCl2, 100 mM tris(hydroxymethyl)aminomethanehydrochloride (pH 8.0), 67 mM mercaptoethanol, and extract in a final volume of 1 ml. Incubation was for 60 min at 30 C. Results with this assay are shown in Table 1 . Enzymatically forned pteroate was measured by microbiological assay with S. faecalis (ATCC 8043) as described by Brown et al.
(2). Since folic acid was used as a stan- dard, the results are presented as "folate equivalents."
Transfer of R factor. Donor and recipient were grown in supplemented minimal medium, donor without and recipient with aeration (shaking), and mixed at 2 x 108 cells per ml for donor J53(Rldrl9) and about 2 x 109 cells per ml for the recipients C-167, C-167ts18, and C-167ts20. The latter three strains were all resistant to nalidixic acid. After 2 h of mixing at 37 C (30 C for ts mutants) with slow shaking, recombinants carrying chloramphenicol resistance (20 jug/ml) and nalidixic acid resistance (40 tLg/ml) were selected for on supplemented minimal agar plates.
RESULTS
Selection of mutants with a temperaturesensitive dihydropteroate synthase. Sulfonamide-resistant mutants ofE. coli were selected with the idea that mutations to resistance would change the sulfonamide target enzyme dihydropteroate synthase to temperature sensitivity in some cases. The E. coli C strain C-167, which is resistant to nalidixic acid, was used as a parent.
Sulfonamide inhibition of bacteria is very sensitive to the dose of inoculation, i.e., large plate inocula (107 to 108 cells) grow virtually unabated in the presence of the drug, probably because the cells contain a supply of folic acid, which is not diluted down to growth inhibitory concentrations until several generations have elapsed. Because of this, two mutant enrichment procedures were employed. In one procedure, an inoculum of about 5 x 108 cells was grown in 50 ml of minimal medium for 6 to 9 days at 30 C in the presence of 0.05 mM sulfathiazole. Samples of about 103 cells were withdrawn at intervals and plated on minimal medium plates containing 0.02 mM sulfathiazole, and resistant colonies were picked. Also, 50. SKO)LD on November 3, 2017 by guest http://aac.asm.org/ Downloaded from a step-wise technique was used. By this technique, about 108 cells were inoculated per tube in a series of tubes each containing 5 ml of minimal medium and increasing concentrations of sulfathiazole (range, 0.01 mM to 0.10 mM). From a tube barely permitting growth a small inoculum was transferred to a new tube containing a slightly higher concentration of sulfonamide and so forth.
By these methods some 20 mutants were obtained, showing varying degrees of resistance. Two of these mutants, labeled C-167ts18 and C-167ts20, were thermosensitive with no colonies formed at 42 C but with normal growth at 30 C even in the presence of 0.02 mM sulfathiazole. The parental strain C-167 grows normally at 42 C, but not at all in the presence of 0.02 mM sulfathiazole either at 30 or 42 C. Growth curves for C-167ts20 and its parental strain C-167 are shown in Fig. 1A . It can be seen that C-167 increases its rate of growth (generation time decreases from 102 to 62 min) at a temperature shift from 30 to 40 C, whereas growth of C-167ts20, after about one generation, Growth curves showing temperature sensitivity of C-167ts20. Cultures were grown in supplemented minimal medium in bubbler tubes and growth was measured by absorbance at 450 nm with a Zeiss PMQ II spectrophotometer. (A) Temperature shift from 30 to 40 C at 72 min. A, C-167; 0, C-167ts20. (B) 0, C-167ts20; x, C-167ts20 with thymidine (10 pglml) and deoxyadenosine (60 pg/ml) added at temperature shift (125 min). starts to slow down almost to a halt. This behavior of temperature sensitivity for C-167ts20 was completely abolished if the experiment shown in Fig. 1A was run in a rich medium containing tryptone and yeast extract (data not shown), and Fig. 1B indicates that the temperature inhibition could be partly reversed by the addition of thymidine and deoxyadenosine to the minimal medium. These observations, which were also made with C-167ts18, are consistent with the existence in the dihydropteroate synthase of a mutational change responsible for both sulfathiazole resistance and temperature sensitivity. At the high temperature the mutant cells would suffer from folic acid deficiency, which could be partly overcome by the exogenous addition of products of folic acid-dependent metabolic reactions. Folic acid itself was found to be inactive in reversing the temperature sensitivity, however. This could be explained by the known impermeability of E. coli to this growth factor. This interpretation, with a lesion in the dihydropteroate-forming enzyme, is also supported by the direct enzyme assays in bacterial extracts shown in Table 2 . It can be seen that extracts from mutants contained only about one-fourth of the activity found in those of the parental strain.
Suppression of temperature sensitivity by an R factor carrying sulfonamide resistance. The temperature-sensitive behavior of strains C-167ts18 and C-167ts20 was markedly changed when Rldrl9 carrying sulfonamide resistance was introduced into them. The derepressed R factor, also mediating resistance to chloramphenicol, ampicillin, streptomycin and kanamycin, was transferred by conjugation to the temperature-sensitive mutants and to their parental strain. Recombinants resistant to both chloramphenicol and nalidixic acid were picked, identified by different markers, and tested for temperature sensitivity (Table 3 ). The presence of Rldrl9 in C-167ts18 and C-167ts20 permits these mutants to grow freely at 42 C, at which temperature the growth of the R-strains is completely inhibited ( Table 3) . Rescue from temperature sensitivity by Rldrl9 is also demonstrated in Fig. 2 , which shows the growth curves. A shift in temperature from 30 to 41 C markedly retards the growth of C-167ts20, whereas the growth of C-167ts20(Rldrl9) proceeds at a rate which is indistinguishable from that of C-167 ( Fig. 2A) . Similarly, growth curves for C-167ts18 and C-167ts18(Rldrl9) show that the latter strain is much less affected by a shift-up in temperature than R-C-167ts18 (Fig. 2B ). In this case the higher temperature was 43 C, which explains the interference with C-167 growth.
Inhibition of dihydropteroate synthase activity by sulfathiazole in extracts from C-167 and C-167(Rldrl9). The results presented in Table  3 and Fig. 2 were interpreted as a rescue by the R factor from the temperature sensitivity caused by the lesion in the chromosomal dihydropteroate synthase. This could be effected by the R factor making the cell diploid for the enzyme, i.e., Rldrl9 would carry an extrachromosomal gene for it. This interpretation is further supported by direct measurements of the pteroate synthesizing activity and its inhibition by sulfathiazole in partially purified extracts from C-167 with and without Rldrl9. The results are presented in Fig. 3 , where a clear distinction is seen in susceptibility to sulfathiazole inhibition between the extracts from R+ and R-cells. The one from C-167-(Rldrl9) is less inhibited, and shows about one-fifth remaining activity at a sulfathiazole concentration at which the extract from Rcells is inhibited more than 95%. DISCUSSION Genetic alterations in the enzymatic, dihydropteroate-forming mechanism was many years ago found to explain certain cases of chromosomal resistance to sulfonamides in E. coli (7) . This explanation, with a dihydropteroate synthase showing decreased susceptibility for sulfonamide inhibition, is not immediately applicable to the R-factor-mediated resistance to this drug, since most known cases ofplasmidborne drug resistance are effected by drugmodifying enzymes. A parallel could, however, be visualized to the earlier described mechanism oftransferable resistance to trimethoprim, where the R factor makes the cell diploid for the target enzyme, one copy type of which is drug unsusceptible (10) .
This work presents two types of evidence for such an analogy, i.e., the occurrence of a dihydropteroate synthase coded for by the R factor. One type of evidence for this diploidy is the R factor rescue from temperature sensitivity of bacteria with a lesion allegedly located in the gene for chromosomal pteroate synthetase. The other evidence regards direct attempts to discern two different activities by enzyme assays.
The first argument would thus rest on the true location of the temperature sensitivity lesion to the chromosomal enzyme. The evidence for this is threefold. (i) Direct measurements of dihydropteroate synthase showed that a Single colonies of the different strains were picked and suspended in 1 ml of mineral salts medium. A loopful of this suspension was inoculated into 5 ml of minimal medium supplemented as indicated: uracil, 40 ,ug/ml; nalidixic acid, 40 pg/ml; chloramphenicol, 20 ,ug/ml; sulfathiazole, 0.50 mM. After growth for 20 h at 30 C (columns 1 to 4) or 42 C (column 5), viable counts were determined on uracil-supplemented minimal agar plates incubated at 30 C. indicates that the plasmid induces the formation of a pteroate synthase to complement the inactivated chromosomal enzyme.
Evidence for an R-factor-specific enzyme was also obtained by direct measurements of dihydropteroate synthase activities in R+ bacteria. Although the rather inaccurate microbiological assay for enzyme product does not allow any determinations of enzyme kinetics, it was demonstrated that extracts from bacteria carrying Rldrl9 contained an activity that was markedly less susceptible to sulfonamide inhibition than the corresponding activity from R-cells.
In conclusion, it is proposed that R-factormediated resistance to sulfonamides in some cases can be explained analogously to R-factorborne trimethoprim resistance (10), i.e., by a plasmid-borne, drug-resistant target enzyme. extracts from mutant bacteria contained much less enzyme activity under standard assay conditions than those frcim the parental strain. (ii) The genetic trait primarily selected for was sulfonamide resistance, which is known to be accompanied by changes in the dihydropteroate synthase (7) . It is therefore very likely that such changes in some cases would result in a temperature-sensitive enzyme. Such a case of temperature sensitivity was in fact observed by Pato and Brown (7) . (iii) The inhibition of growth at an elevated temperature could be partly relieved by the addition of nucleic acid precursors, the synthesis of which is dependent on folic acid. The complete relief of growth inhibition at high temperature by the presence of Rldrl9 (cf. Fig. 2A) 
